Finland Biotechnology & Medical Research

Faron Pharmaceuticals Oy (FARN)

Track

The most recent insider trading activity occurred on March 1, 2026, with multiple buy transactions totaling over $250,000. Prior to this, significant buy transactions were noted on April 3, 2024. The last sell transaction was on October 12, 2023. Overall, recent activity shows a pattern of insider buying.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: FARN Exchange: LSE

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Tuomo Pätsi

Non-Executive Chairman

1 purchase — total 200,001 EUR

Buy 1 Mar 2026

Value €1,156,482.83 | Price 13.79 | Shares 59,740

Sirpa Jalkanen

PCA

1 purchase — total 50,004 EUR

Buy 1 Mar 2026

Value €1,791,182.05 | Price 265.53 | Shares 87,167

Tuomo Pätsi

Director

1 purchase — total 119,999 EUR

Buy 3 Apr 2024

Value €119,998.50 | Price 1.50 | Shares 79,999

Sirpa Jalkanen

Director

1 purchase — total 119,999 EUR

Buy 3 Apr 2024

Value €119,998.50 | Price 1.50 | Shares 79,999

Markku Jalkanen

Director

1 purchase — total 119,999 EUR

Buy 3 Apr 2024

Value €119,998.50 | Price 1.50 | Shares 79,999

John Poulos

Non-executive Director

1 sale — total 19,130 EUR

Sale 12 Oct 2023

Value €19,129.50 | Price 3.83 | Shares 5,000

John Poulos

Non-executive Director

1 sale — total 18,605 EUR

Sale 3 Oct 2023

Value €18,604.50 | Price 3.72 | Shares 5,000

Markku Jalkanen

Chief Executive Officer

1 purchase — total 70,533 EUR

Buy 5 Apr 2022

Value €70,532.50 | Price 2.82 | Shares 25,000

Toni HÄonninen

Chief Financial Officer

1 purchase — total 15,444 GBP

Buy 8 Jul 2020

Value £15,444.00 | Price 3.51 | Shares 4,400

Toni HÄonninen

Chief Financial Officer

1 purchase — total 15,139 EUR

Buy 12 May 2020

Value €15,139.30 | Price 4.33 | Shares 3,500

Matti Karvonen

VP Drug Development, Chief Medical Officer

1 purchase — total 16,580 GBP

Buy 26 Oct 2018

Value £16,580.00 | Price 0.83 | Shares 20,000

Minja Pfeiffer

Chief Medical Officer

1 purchase — total 4,414 GBP

Buy 17 Sep 2018

Value £4,414.00 | Price 1.00 | Shares 4,414

Juho Jalkanen

Chief Development Officer

1 purchase — total 8,520 GBP

Buy 21 Jun 2018

Value £8,520.00 | Price 0.71 | Shares 12,000

Mehto Saima Kuolinpesä

Chief Development Officer

1 purchase — total 17,040 GBP

Buy 21 Jun 2018

Value £17,040.00 | Price 0.71 | Shares 24,000

Markku Jalkanen

Chief Development Officer

1 purchase — total 8,520 GBP

Buy 21 Jun 2018

Value £8,520.00 | Price 0.71 | Shares 12,000

Minja Pfeiffer

Chief Development Officer

1 purchase — total 17,670 GBP

Buy 21 Jun 2018

Value £17,670.00 | Price 0.57 | Shares 31,000

Matti Karvonen

Chief Executive Officer

1 purchase — total 8,400 GBP

Buy 21 Jun 2018

Value £8,400.00 | Price 0.56 | Shares 15,000

Through Matti Karvonen, a closely affiliated person

Pessi Honkasalo

Medical Director

1 purchase — total 1,125 GBP

Buy 21 Jun 2018

Value £1,125.00 | Price 0.75 | Shares 1,500

Yrjö Wichmann

Corporate Legal Counsel

1 purchase — total 3,484 GBP

Buy 21 Jun 2018

Value £3,484.00 | Price 0.67 | Shares 5,200

Susanna Hedenström

Chief Financial Officer

1 purchase — total 4,424 GBP

Buy 21 Jun 2018

Value £4,424.00 | Price 0.56 | Shares 7,900

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-03-31	2026-03-01	B Purchase	Tuomo Pätsi Non-Executive Chairman Director	59,740 13.79 €1,156,483	59,740	13.79	€1,156,483
2026-03-25	2026-03-01	B Purchase	Sirpa Jalkanen PCA	87,167 265.53 €1,791,182	87,167	265.53	€1,791,182
2024-04-04	2024-04-03	B Purchase	Tuomo Pätsi Director Executive Director	12,958 258.14 €3,795,489	12,958	258.14	€3,795,489
2024-04-04	2024-04-03	B Purchase	Sirpa Jalkanen Director Executive Director	79,999 1.50 €119,998	79,999	1.50	€119,998
2024-04-04	2024-04-03	B Purchase	2.2 Markku Jalkanen Director Executive Director	79,999 1.50 €119,998	79,999	1.50	€119,998
2023-10-27	2023-10-12	S Sale	John Poulos Non-executive Director Executive Director	5,000 3.83 €19,130	5,000	3.83	€19,130
2023-10-27	2023-10-03	S Sale	John Poulos Non-executive Director Executive Director	5,000 3.72 €18,604	5,000	3.72	€18,604
2022-04-08	2022-04-05	B Purchase	2.2 Markku Jalkanen Chief Executive Officer Officer	25,000 2.82 €70,532	25,000	2.82	€70,532
2020-07-08	2020-07-08	B Purchase	2.4 Toni HÄonninen Chief Financial Officer Officer	4,400 3.51 £15,444	4,400	3.51	£15,444
2020-05-12	2020-05-12	B Purchase	2.4 Toni HÄonninen Chief Financial Officer Officer	3,500 4.33 €15,139	3,500	4.33	€15,139
2018-11-06	2018-10-26	B Purchase	1.1 Matti Karvonen VP Drug Development, Chief Medical Officer Officer	20,000 0.83 £16,580	20,000	0.83	£16,580
2018-09-18	2018-09-17	B Purchase	1.4 Minja Pfeiffer Chief Medical Officer Officer	4,414 1.00 £4,414	4,414	1.00	£4,414
2018-06-21	2018-06-21	B Purchase	3.2 Juho Jalkanen Chief Development Officer Officer	12,000 0.71 £8,520	12,000	0.71	£8,520
2018-06-21	2018-06-21	B Purchase	Mehto Saima Kuolinpesä Chief Development Officer Officer	24,000 0.71 £17,040	24,000	0.71	£17,040
2018-06-21	2018-06-21	B Purchase	2.2 Markku Jalkanen Chief Development Officer Officer	12,000 0.71 £8,520	12,000	0.71	£8,520
2018-06-21	2018-06-21	B Purchase	1.4 Minja Pfeiffer Chief Development Officer Officer	31,000 0.57 £17,670	31,000	0.57	£17,670
2018-06-21	2018-06-21	B Purchase	1.1 Matti Karvonen Chief Executive Officer Through Matti Karvonen, a closely affiliated person Officer	15,000 0.56 £8,400	15,000	0.56	£8,400
2018-06-21	2018-06-21	B Purchase	3.1 Pessi Honkasalo Medical Director Executive Director	1,500 0.75 £1,125	1,500	0.75	£1,125
2018-06-21	2018-06-21	B Purchase	3.3 Yrjö Wichmann Corporate Legal Counsel	5,200 0.67 £3,484	5,200	0.67	£3,484
2018-06-21	2018-06-21	B Purchase	Susanna Hedenström Chief Financial Officer Officer	7,900 0.56 £4,424	7,900	0.56	£4,424